Search results
Results from the WOW.Com Content Network
Ethicon, Inc. is a subsidiary of Johnson & Johnson. The company is part of the Johnson & Johnson MedTech business segment. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and
On Jan 23, 2009, Mentor was acquired by Johnson & Johnson, [8] [9] and is a stand-alone business unit reporting through Ethicon, Inc., a Johnson & Johnson company and provider of suture, mesh, hemostats, and other products for surgical procedures. Johnson & Johnson company markets its breast implant products in India with the name MentorConfidence.
In January 2010, Ethicon Inc., a Johnson & Johnson company, completed the acquisition of Acclarent. [6] In September 2017, the firm received FDA clearance for the Aera balloon, the first ever device to treat chronic eustachian tube dysfunction. In December 2023, Integra LifeSciences announced they were acquiring Acclarent for $275m. [7]
In many other countries, DePuy operates as a brand under the Johnson & Johnson Medical organization. [ 1 ] DePuy is currently the subject of more than 11,000 lawsuits related to its recall of faulty hip replacement systems, which lawyers and industry analysts estimate will cost parent company Johnson & Johnson billions of dollars to resolve.
This page was last edited on 11 January 2023, at 17:03 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
This page was last edited on 11 December 2024, at 07:02 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
He joined the company as a sales representative for the McNeil Pharmaceutical division in 1971 and eventually became the head of Johnson & Johnson's Ethicon Endo-Surgery business in 1992. He became the head of Johnson & Johnson's pharmaceutical operations in 1998 and then became the company's chief executive officer (CEO) in 2002.
Vicryl (polyglactin 910) is an absorbable, synthetic, usually braided suture, manufactured by Ethicon Inc., a subsidiary of Johnson and Johnson. A monofilament version is also made for use in ophthalmic practice. It is indicated for soft tissue approximation and ligation.